Comprehensive medication guide to Pantoprazole including estimated pricing, availability information, side effects, and how to find it in stock at your local pharmacy.
Estimated Insurance Pricing
$0–$30 copay for generic on most commercial plans, Medicare Part D, and Medicaid; typically Tier 1–2. Brand Protonix may require step therapy or prior authorization. Quantity limits may apply for 90-day supplies.
Estimated Cash Pricing
$67 average retail for generic pantoprazole 40 mg (30 tablets); as low as $9 with GoodRx or $7–$9 with SingleCare coupons for a 30-day supply. Brand Protonix can cost $780–$1,300 without insurance.
Medfinder Findability Score
82/100
Summarize with AI
On this page
Pantoprazole is a proton pump inhibitor (PPI) that reduces the amount of acid produced in the stomach. Available generically and under the brand name Protonix, it is one of the most commonly prescribed medications in the United States, dispensed tens of millions of times each year.
It is FDA-approved for the treatment and maintenance of erosive esophagitis associated with gastroesophageal reflux disease (GERD) in adults and children aged 5 years and older, as well as for pathological hypersecretory conditions including Zollinger-Ellison Syndrome. Pantoprazole is available as delayed-release oral tablets (20 mg and 40 mg), oral suspension granules, and an intravenous formulation for hospital use.
Unlike omeprazole and esomeprazole, pantoprazole is available only by prescription and does not have an FDA-approved over-the-counter formulation. It is not a controlled substance.
We have a 99% success rate finding medications, even during nationwide shortages.
Need this medication?
Pantoprazole is a prodrug that becomes active after absorption in the small intestine. It accumulates in the highly acidic secretory canaliculi of gastric parietal cells, where it is converted to its active sulfenamide form. This active metabolite forms an irreversible covalent bond with cysteine residues on the H+/K+ ATPase enzyme — the proton pump — permanently blocking it from secreting hydrogen ions (protons) into the stomach.
Because pantoprazole permanently deactivates individual proton pumps, acid secretion resumes only when the body synthesizes new, unblocked pumps — a process that takes approximately 18–24 hours per pump. Maximum acid suppression (>90% of active pumps blocked) is typically achieved after 3–5 days of consistent daily dosing.
Compared to H2 blockers (e.g., famotidine), which reduce signals that stimulate acid production, PPIs like pantoprazole act at the final step of acid secretion and provide deeper, longer-lasting suppression. Pantoprazole is also notable for its lower CYP2C19 inhibition compared to omeprazole and esomeprazole, resulting in fewer drug-drug interactions.
20 mg — delayed-release tablet
Used for children 5-16 years weighing 15-39 kg; also available for adults as alternative dosing
40 mg — delayed-release tablet
Standard adult dose; most commonly dispensed form; taken once daily for GERD/EE
40 mg — delayed-release oral suspension granule packet
For patients unable to swallow tablets; mix with apple juice or applesauce only
40 mg — intravenous injection/infusion
Hospital use only for short-term GERD treatment (up to 10 days) or ZE syndrome management
Generic pantoprazole 40 mg delayed-release tablets are generally widely available and are not currently listed as a nationally shortage drug by the FDA or ASHP (as of 2026). As one of the top 20 most dispensed prescription drugs in the US, it is stocked by virtually every major chain pharmacy and most independent pharmacies.
However, individual pharmacies may experience temporary stock gaps due to high local demand or distribution delays. The 40 mg oral suspension granule formulation is less commonly stocked and may require a special pharmacy order. Intravenous pantoprazole has experienced periodic shortages affecting hospital settings.
If you're having trouble filling your pantoprazole prescription, medfinder calls pharmacies near you to find out which ones have your medication in stock, with results sent directly to your phone by text.
Pantoprazole is not a controlled substance, so it can be prescribed by any licensed prescriber in the United States without DEA scheduling restrictions. It is commonly prescribed in both outpatient and inpatient settings.
Primary care physicians (PCPs) — family medicine, internal medicine, general practitioners
Gastroenterologists — for complex GERD, erosive esophagitis, ZE syndrome, Barrett's esophagus
Nurse practitioners (NPs) and physician assistants (PAs)
Urgent care providers
Hospitalists and emergency medicine physicians (for IV and oral inpatient use)
Pantoprazole is widely available via telehealth. Since GERD can typically be diagnosed based on symptom history, telehealth platforms including Teladoc, MDLive, Amazon Clinic, and One Medical can evaluate symptoms and prescribe pantoprazole during a virtual visit.
No. Pantoprazole is not a controlled substance and is not scheduled by the DEA. It does not have abuse potential or known dependence liability. As a non-controlled prescription drug, pantoprazole prescriptions can be transferred freely between pharmacies, refilled without special procedures, and prescribed via telehealth without additional regulatory restrictions.
A valid prescription from a licensed healthcare provider is required to dispense pantoprazole in the US, as it is not available over the counter. However, the prescription process is straightforward through any licensed prescriber including primary care physicians, nurse practitioners, physician assistants, and telehealth providers.
The following side effects occur in more than 2% of adult patients in clinical trials:
Headache
Diarrhea
Nausea
Abdominal pain
Vomiting
Flatulence
Dizziness
Joint pain (arthralgia)
C. difficile-associated diarrhea — call your doctor for persistent or bloody diarrhea
Acute tubulointerstitial nephritis — decreased urine output, blood in urine
Vitamin B-12 deficiency — with long-term use (>3 years)
Bone fractures — with long-term or high-dose use
Drug-induced lupus (cutaneous or systemic) — rash, joint pain
Severe skin reactions (rare): Stevens-Johnson syndrome, toxic epidermal necrolysis
Hypomagnesemia — low magnesium with prolonged use
Know what you need? Skip the search.
Omeprazole (Prilosec)
Available OTC (20 mg) and Rx; therapeutically equivalent at 20 mg vs pantoprazole 40 mg; more drug interactions via CYP2C19
Esomeprazole (Nexium)
Available OTC (20 mg) and Rx; S-isomer of omeprazole; similar efficacy; some studies show faster symptom relief
Lansoprazole (Prevacid)
Available OTC (15 mg) and Rx; ODT dissolving tablet form available for patients with dysphagia; similar efficacy
Famotidine (Pepcid)
H2 blocker (different drug class); OTC available; less potent than PPIs; faster onset for acute symptoms
Prefer Pantoprazole? We can find it.
Rilpivirine (Edurant)
majorContraindicated. PPIs raise gastric pH and reduce rilpivirine absorption, risking HIV treatment failure and resistance development.
Nelfinavir (Viracept)
majorContraindicated. Reduced nelfinavir levels via pH and CYP2C19 mechanisms may cause virologic failure.
Methotrexate
majorMay increase methotrexate levels by reducing renal tubular secretion, increasing toxicity risk. Consider temporary pantoprazole discontinuation around methotrexate dosing.
Mycophenolate mofetil (CellCept)
majorPantoprazole reduces MPA (active metabolite) Cmax by up to 78% and AUC by up to 45%. Monitor and adjust in transplant patients.
Clopidogrel (Plavix)
moderateReduces clopidogrel active metabolite by ~14%. Pantoprazole is the preferred PPI for patients on dual antiplatelet therapy due to lowest CYP2C19 inhibition.
Digoxin (Lanoxin)
moderateElevated gastric pH may increase digoxin absorption and serum levels. Monitor digoxin levels when starting or stopping pantoprazole.
Warfarin (Coumadin)
moderatePost-marketing reports of increased INR and prothrombin time. Monitor INR more frequently when pantoprazole is started or stopped.
Iron salts (ferrous sulfate)
minorReduced iron absorption due to elevated gastric pH. Take iron 1–2 hours before pantoprazole for best absorption.
Pantoprazole is a safe, effective, and widely available treatment for GERD, erosive esophagitis, and acid hypersecretory conditions. As a generic medication, it is one of the most affordable prescription drugs on the market — with coupon prices as low as $7–$9 per month for most patients. Its favorable drug interaction profile (lower CYP2C19 inhibition compared to omeprazole) makes it a first-choice PPI for patients on clopidogrel or complex medication regimens.
While pantoprazole is not currently in national shortage, individual pharmacy stock gaps can occur. Long-term use requires monitoring for vitamin B-12 deficiency, magnesium levels, and bone health — discuss periodic reviews with your doctor if you've been on pantoprazole for more than a year.
If you're having trouble finding pantoprazole at your pharmacy, medfinder can help you locate pharmacies near you that have it in stock — no hold music required. Enter your medication and zip code, and we'll call the pharmacies and text you the results.
Medfinder Editorial Standards
Our medication guides are researched and written to help patients make informed decisions. All content is reviewed for accuracy and updated regularly. Learn more about our standards